BioRestorative enters into $3.6M ATM offering agreement with Rodman & Renshaw; terminates prior JonesTrading ATM

BioRestorative Therapies, Inc.

Entered ATM agreement with Rodman & Renshaw on Nov 6, 2024 for up to $3.6M of common stock.
Agent will receive 3.0% commission on gross sales proceeds; company not obligated to sell any shares.
Prior ATM with JonesTrading terminated on Nov 1, 2024; $622,235 of shares sold under that agreement.
Offering made under existing effective S-3 registration statement filed Feb 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.